KOPRESKI MICHAEL S has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, machines and measurement are WUHAN ADICON CLINICAL LABORATORIES INC, INSPECTION AND QUARANTINE TECHNOLOGY CT ZHEJIANG ENTRY EXIT INSPECTION AND QUARANTINE BUREAU and CHEMICALS EVALUATION & RES INS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Machines | |
#3 | Measurement | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Unspecified technologies | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kopreski Michael S | 14 |
#2 | Gocke Christopher D | 1 |
Publication | Filing date | Title |
---|---|---|
US2015232933A1 | Methods for evaluating pathologic conditions using extracellular rna | |
US2009111097A1 | Comparative analysis of extracellular RNA species | |
US2008050783A1 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer | |
US2007009934A1 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer | |
US2006204989A1 | Comparative analysis of extracellular RNA species | |
WO03076589A2 | Analysis of apoptotic bodies in bodily fluids | |
CA2250118A1 | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |